MHRA strengthening dependency and addiction warnings on medicines used to treat pain, anxiety, and insomnia

MHRA strengthening dependency and addiction warnings on medicines used to treat pain, anxiety, and insomnia

Following a comprehensive safety review by the Medicines and Healthcare products Regulatory Agency (MHRA), warnings on…

Continue Reading
MHRA review highlights how to transform women’s health

MHRA review highlights how to transform women’s health

A new review co-authored by the Medicines and Healthcare products Regulatory Agency has highlighted the vaginal…

Continue Reading
MHRA to review blood monitoring requirements for clozapine patients

MHRA to review blood monitoring requirements for clozapine patients

The Medicines and Healthcare products Regulatory Agency (MHRA) is reviewing blood monitoring requirements for patients using…

Continue Reading
MHRA to review evidence of harm linked to pseudoephedrine-containing medicines

MHRA to review evidence of harm linked to pseudoephedrine-containing medicines

The Medicines and Healthcare products Regulatory Agency (MHRA) is reviewing available evidence on potentially serious side…

Continue Reading
OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

NEW YORK, March 11, 2025–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies…

Continue Reading
MHRA warns of unsafe counterfeit anti-choking devices

MHRA warns of unsafe counterfeit anti-choking devices

The Medicines and Healthcare products Regulatory Agency (MHRA) is warning the public not to buy counterfeit…

Continue Reading